In this PCR webinar, F. Ribichini, F. Alfonso Manterola and D. Mylotte discuss which kind of vessels with the de-novo lesions could be considered for a “DCB-alone” PCI strategy, how to prepare the vessel, deliver the therapy, and evaluate the results. 

Determine which kind of vessels with the de-novo lesions could be considered for a “DCB-alone” PCI strategy

Understand how to prepare the vessel, deliver the therapy, and evaluate the immediate results after “DCB-alone” PCI

Understand complications and long-term results

How and when should I consider Drug Coated Balloons to treat de novo lesions?

Complex PCI Case Discussion supported by Medtronic

Complex PCI with the Prevail DCB

Discover more about the use of DCBs in complex PCI with modules on the science, trials, indications and practical tips and tricks with Prevail.

MedShr Editor

In discussion with Carolin Jennessen, Vascular Therapy Training Specialist, Prof Bruno Scheller shares his DCB insights. From the science to clinical practice with key PCI indications including ISR and small vessels

Prevail DCB: from science to practice - Prof Bruno Scheller 

Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study